About Proscia
Proscia is a company based in Philadelphia (United States) founded in 2014 by Nathan Buchbinder and Coleman Stavish.. Proscia has raised $129.23 million across 8 funding rounds from investors including Avenue Capital Group, TEDCO and ROBO Global. The company has 85 employees as of December 31, 2022. Proscia offers products and services including Concentriq Enterprise Pathology Platform, Concentriq AP, and Concentriq AP-Dx. Proscia operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter Philadelphia, United States
- Employees 85 as on 31 Dec, 2022
- Founders Nathan Buchbinder, Coleman Stavish
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Proscia Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$129.23 M (USD)
in 8 rounds
-
Latest Funding Round
$50 M (USD), Series C
Mar 04, 2025
-
Investors
Avenue Capital Group
& 18 more
-
Employee Count
85
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proscia
Proscia offers a comprehensive portfolio of products and services, including Concentriq Enterprise Pathology Platform, Concentriq AP, and Concentriq AP-Dx. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for AI-driven pathology analysis in medical diagnostics.
Software for digitizing and analyzing anatomic pathology specimens.
AI tool for precise diagnostic use in pathology workflows.
Unlock access to complete
Funding Insights of Proscia
Proscia has successfully raised a total of $129.23M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series C — $50.0M
-
First Round
First Round
(05 Jul 2016)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series C - Proscia | Valuation | Insight Partners , AI Capital | |
| Dec, 2023 | Amount | Series C - Proscia | Valuation | Highline Capital , Triangle Peak Partners | |
| Jun, 2022 | Amount | Series C - Proscia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Proscia
Proscia has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Avenue Capital Group, TEDCO and ROBO Global. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm scaling software and technology companies from early to late stages.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Private equity and VC-based investment firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Proscia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Proscia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Proscia Comparisons
Competitors of Proscia
Proscia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| domain | founded_year | HQ Location |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Proscia
Frequently Asked Questions about Proscia
When was Proscia founded?
Proscia was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is Proscia located?
Proscia is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Proscia a funded company?
Proscia is a funded company, having raised a total of $129.23M across 8 funding rounds to date. The company's 1st funding round was a Series C of $37M, raised on Jul 05, 2016.
How many employees does Proscia have?
As of Dec 31, 2022, the latest employee count at Proscia is 85.
What does Proscia do?
Proscias is a cloud-based software platform that clinic management, analysis, access, and collaboration for slide images in digital pathology. The features of the Proscia platform that allow users to improve whole slide image workflows include secure storage, annotation, and collaboration on digital biopsies. The company has developed a digital pathology platform called Concentriq that uses AI technology for computational pathology applications. The company has developed a tool that assists helathacre providers to diagnose cancer cells using image analysis technology.
Who are the top competitors of Proscia?
Proscia's top competitors include Aignostics, Deciphex and Pictor Labs.
What products or services does Proscia offer?
Proscia offers Concentriq Enterprise Pathology Platform, Concentriq AP, and Concentriq AP-Dx.
Who are Proscia's investors?
Proscia has 19 investors. Key investors include Avenue Capital Group, TEDCO, ROBO Global, Insight Partners, and AI Capital.